Clinical Trials Browser

Phase 2/3 × Advanced Gastric or EGJ Cancer × Ramucirumab × Clear all

NCT03081143 2024-12-12

RAMIRIS

Phase 2/3 Active not recruiting

Gastrointestinal

Advanced Gastric or EGJ Cancer